Markets

News Details

( 11 Feb 2019)
Glenmark Pharma - Press Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 11, 2019, titled "Glenmark Pharmaceuticals receives ANDA approval for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg".